C1778 Insurance Policy Changes

HCPCS C1778 is officially defined as "Lead, neurostimulator (implantable)." HCPCS C1778 is referenced in 4 tracked payer policy changes from Capital Blue Cross and Health Net. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS C1778 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.